Klaria Pharma (Sweden) Buy Hold or Sell Recommendation
| KLAR Stock | SEK 1.14 0.11 10.68% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Klaria Pharma Holding is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Klaria Pharma Holding given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Klaria Pharma Holding, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Klaria Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Klaria and provide practical buy, sell, or hold advice based on investors' constraints. Klaria Pharma Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Klaria |
Execute Klaria Pharma Buy or Sell Advice
The Klaria recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Klaria Pharma Holding. Macroaxis does not own or have any residual interests in Klaria Pharma Holding or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Klaria Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Klaria Pharma Trading Alerts and Improvement Suggestions
| Klaria Pharma is way too risky over 90 days horizon | |
| Klaria Pharma may become a speculative penny stock | |
| Klaria Pharma appears to be risky and price may revert if volatility continues | |
| Klaria Pharma Holding has accumulated 1.02 M in total debt. Klaria Pharma Holding has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Klaria Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Klaria Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Klaria Pharma Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Klaria to invest in growth at high rates of return. When we think about Klaria Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (53.53 M) with profit before overhead, payroll, taxes, and interest of 5.87 M. | |
| Klaria Pharma Holding has accumulated about 25.49 M in cash with (24.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47. |
Klaria Pharma Returns Distribution Density
The distribution of Klaria Pharma's historical returns is an attempt to chart the uncertainty of Klaria Pharma's future price movements. The chart of the probability distribution of Klaria Pharma daily returns describes the distribution of returns around its average expected value. We use Klaria Pharma Holding price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Klaria Pharma returns is essential to provide solid investment advice for Klaria Pharma.
| Mean Return | 2.65 | Value At Risk | -10.43 | Potential Upside | 21.33 | Standard Deviation | 17.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Klaria Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Klaria Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Klaria Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Klaria Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Klaria stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 3.04 | |
β | Beta against Dow Jones | 3.67 | |
σ | Overall volatility | 18.38 | |
Ir | Information ratio | 0.15 |
Klaria Pharma Volatility Alert
Klaria Pharma Holding is displaying above-average volatility over the selected time horizon. Klaria Pharma Holding is a potential penny stock. Although Klaria Pharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Klaria Pharma Holding. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Klaria instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Klaria Pharma Fundamentals Vs Peers
Comparing Klaria Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Klaria Pharma's direct or indirect competition across all of the common fundamentals between Klaria Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Klaria Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Klaria Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Klaria Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Klaria Pharma to competition |
| Fundamentals | Klaria Pharma | Peer Average |
| Return On Equity | -0.88 | -0.31 |
| Return On Asset | -0.29 | -0.14 |
| Operating Margin | (9.48) % | (5.51) % |
| Current Valuation | 88.14 M | 16.62 B |
| Shares Outstanding | 63.1 M | 571.82 M |
| Shares Owned By Insiders | 10.73 % | 10.09 % |
| Shares Owned By Institutions | 9.75 % | 39.21 % |
| Price To Earning | (18.43) X | 28.72 X |
| Price To Book | 1.42 X | 9.51 X |
| Price To Sales | 8.00 X | 11.42 X |
| Gross Profit | 5.87 M | 27.38 B |
| EBITDA | (39.41 M) | 3.9 B |
| Net Income | (53.53 M) | 570.98 M |
| Cash And Equivalents | 25.49 M | 2.7 B |
| Cash Per Share | 0.47 X | 5.01 X |
| Total Debt | 1.02 M | 5.32 B |
| Current Ratio | 0.68 X | 2.16 X |
| Book Value Per Share | 0.97 X | 1.93 K |
| Cash Flow From Operations | (24.8 M) | 971.22 M |
| Earnings Per Share | (1.72) X | 3.12 X |
| Number Of Employees | 6 | 18.84 K |
| Beta | 0.39 | -0.15 |
| Market Capitalization | 39.49 M | 19.03 B |
| Total Asset | 118.31 M | 29.47 B |
| Retained Earnings | (9 M) | 9.33 B |
| Working Capital | 41 M | 1.48 B |
| Current Asset | 44 M | 9.34 B |
| Current Liabilities | 3 M | 7.9 B |
| Z Score | 22.8 | 8.72 |
| Net Asset | 118.31 M |
Klaria Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Klaria . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Klaria Pharma Buy or Sell Advice
When is the right time to buy or sell Klaria Pharma Holding? Buying financial instruments such as Klaria Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Klaria Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Currency Funds Thematic Idea Now
Currency Funds
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.